Pamela P. Palmer
2011
In 2011, Pamela P. Palmer earned a total compensation of $950.7K as Chief Medical Officer at AcelRx Pharmaceuticals, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $89,513 |
|---|---|
| Option Awards | $243,000 |
| Salary | $385,000 |
| Stock Awards | $233,199 |
| Total | $950,712 |
Palmer received $385K in salary, accounting for 40% of the total pay in 2011.
Palmer also received $89.5K in non-equity incentive plan, $243K in option awards and $233.2K in stock awards.
Rankings
In 2011, Pamela P. Palmer's compensation ranked 5,825th out of 10,747 executives tracked by ExecPay. In other words, Palmer earned more than 45.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,825 out of 10,747 | 46th |
Division Manufacturing | 2,103 out of 3,960 | 47th |
Major group Chemicals And Allied Products | 467 out of 1,033 | 55th |
Industry group Drugs | 297 out of 781 | 62nd |
Industry Pharmaceutical Preparations | 234 out of 571 | 59th |
Source: SEC filing on August 6, 2013.
Palmer's colleagues
We found four more compensation records of executives who worked with Pamela P. Palmer at AcelRx Pharmaceuticals in 2011.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019